Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 104 of the 106 references it cites were found in a registry or an index; 23 of the 73 sources its claims cite were checked for support.

Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

Open access
Ledesma, Jorge R, Ma, Jianing, Zhang, Meixin, Basting, Ann V L, Chu, Huong Thi, Vongpradith, Avina, Novotney, Amanda, LeGrand, Kate E, Xu, Yvonne Yiru, Dai, Xiaochen, Nicholson, Sneha Ingle, Stafford, Lauryn K, Carter, Austin, Ross, Jennifer M, Abbastabar, Hedayat, Abdoun, Meriem, Abdulah, Deldar Morad, Aboagye, Richard Gyan, Abolhassani, Hassan, Abrha, Woldu Aberhe, Abubaker Ali, Hiwa, Abu-Gharbieh, Eman, Aburuz, Salahdein, Addo, Isaac Yeboah, Adepoju, Abiola Victor, Adhikari, Kishor, Adnani, Qorinah Estiningtyas Sakilah, Adra, Saryia, Afework, Abel, Aghamiri, Shahin, Agyemang-Duah, Williams, Ahinkorah, Bright Opoku, Ahmad, Danish, Ahmad, Sajjad, Ahmadzade, Amir Mahmoud, Ahmed, Haroon, Ahmed, Mohammed, Ahmed, Ayman, Akinosoglou, Karolina, AL-Ahdal, Tareq Mohammed Ali, Alam, Nazmul, Albashtawy, Mohammed, AlBataineh, Mohammad T, Al-Gheethi, Adel Ali Saeed, Ali, Abid, Ali, Endale Alemayehu, Ali, Liaqat, Ali, Zahid, Ali, Syed Shujait Shujait, Allel, Kasim, Altaf, Awais, Al-Tawfiq, Jaffar A, Alvis-Guzman, Nelson, Alvis-Zakzuk, Nelson J., Amani, Reza, Amusa, Ganiyu Adeniyi, Amzat, Jimoh, Andrews, Jason R, Anil, Abhishek, Anwer, Razique, Aravkin, Aleksandr Y, Areda, Damelash, Artamonov, Anton A, Aruleba, Raphael Taiwo, Asemahagn, Mulusew A, Atre, Sachin R, Aujayeb, Avinash, Azadi, Davood, Azadnajafabad, Sina, Azzam, Ahmed Y, Badar, Muhammad, Badiye, Ashish D, Bagherieh, Sara, Bahadorikhalili, Saeed, Baig, Atif Amin, Banach, Maciej, Banik, Biswajit, Bardhan, Mainak, Barqawi, Hiba Jawdat, Basharat, Zarrin, Baskaran, Pritish, Basu, Saurav, Beiranvand, Maryam, Belete, Melaku Ashagrie, Belew, Makda Abate, Belgaumi, Uzma Iqbal, Beloukas, Apostolos, Bettencourt, Paulo J G, Bhagavathula, Akshaya Srikanth, Bhardwaj, Nikha, Bhardwaj, Pankaj, Bhargava, Ashish, Bhat, Vivek, Bhatti, Jasvinder Singh, Bhatti, Gurjit Kaur, Bikbov, Boris, Bitra, Veera R, Bjegovic-Mikanovic, Vesna, Buonsenso, Danilo, Burkart, Katrin, Bustanji, Yasser, Butt, Zahid A, Camargos, Paulo, Cao, Yu, Carr, Sinclair, Carvalho, Felix, Cegolon, Luca, Cenderadewi, Muthia, Cevik, Muge, Chahine, Yaacoub, Chattu, Vijay Kumar, Ching, Patrick R, Chopra, Hitesh, Chung, Eunice, Claassens, Mareli M, Coberly, Kaleb, Cruz-Martins, Natália, Dabo, Bashir, Dadana, Sriharsha, Dadras, Omid, Darban, Isaac, Darega Gela, Jiregna, Darwesh, Aso Mohammad, Dashti, Mahmood, Demessa, Berecha Hundessa, Demisse, Biniyam, Demissie, Solomon, Derese, Awoke Masrie Asrat, Deribe, Kebede, Desai, Hardik Dineshbhai, Devanbu, Vinoth Gnana Chellaiyan, Dhali, Arkadeep, Dhama, Kuldeep, Dhingra, Sameer, Do, Thao Huynh Phuong, Dongarwar, Deepa, Dsouza, Haneil Larson, Dube, John, Dziedzic, Arkadiusz Marian, Ed-Dra, Abdelaziz, Efendi, Ferry, Effendi, Diyan Ermawan, Eftekharimehrabad, Aziz, Ekadinata, Nopryan, Ekundayo, Temitope Cyrus, Elhadi, Muhammed, Elilo, Legesse Tesfaye, Emeto, Theophilus I, Engelbert Bain, Luchuo, Fagbamigbe, Adeniyi Francis, Fahim, Ayesha, Feizkhah, Alireza, Fetensa, Getahun, Fischer, Florian, Gaipov, Abduzhappar, Gandhi, Aravind P, Gautam, Rupesh K, Gebregergis, Miglas W, Gebrehiwot, Mesfin, Gebrekidan, Kahsu Gebrekirstos, Ghaffari, Kazem, Ghassemi, Fariba, Ghazy, Ramy Mohamed, Goodridge, Amador, Goyal, Anmol, Guan, Shi-Yang, Gudeta, Mesay Dechasa, Guled, Rashid Abdi, Gultom, Novianti Br, Gupta, Veer Bala, Gupta, Vivek Kumar, Gupta, Sapna, Hagins, Hailey, Hailu, Semira Goitom, Hailu, Wase Benti, Hamidi, Samer, Hanif, Asif, Harapan, Harapan, Hasan, Rumina Syeda, Hassan, Shoaib, Haubold, Johannes, Hezam, Kamal, Hong, Sung Hwi, Horita, Nobuyuki, Hossain, Md. Belal, Hosseinzadeh, Mehdi, Hostiuc, Mihaela, Hostiuc, Sorin, Huynh, Hong-Han, Ibitoye, Segun Emmanuel, Ikuta, Kevin S, Ilic, Irena M., Ilic, Milena D., Islam, Md. Rabiul, Ismail, Nahlah Elkudssiah, Ismail, Faisal, Jafarzadeh, Abdollah, Jakovljevic, Mihajlo, Jalili, Mahsa, Janodia, Manthan Dilipkumar, Jomehzadeh, Nabi, Jonas, Jost B, Joseph, Nitin, Joshua, Charity Ehimwenma, Kabir, Zubair, Kamble, Bhushan Dattatray, Kanchan, Tanuj, Kandel, Himal, Kanmodi, Kehinde Kazeem, Kantar, Rami S, Karaye, Ibraheem M, Karimi Behnagh, Arman, Kassa, Gebrehiwot G, Kaur, Rimple Jeet, Kaur, Navjot, Khajuria, Himanshu, Khamesipour, Faham, Khan, Yusra H, Khan, M Nuruzzaman, Khan Suheb, Mahammed Ziauddin, Khatab, Khaled, Khatami, Fatemeh, Kim, Min Seo, Kosen, Soewarta, Koul, Parvaiz A, Koulmane Laxminarayana, Sindhura Lakshmi, Krishan, Kewal, Kucuk Bicer, Burcu, Kuddus, Md Abdul, Kulimbet, Mukhtar, Kumar, Nithin, Lal, Dharmesh Kumar, Landires, Iván, Latief, Kamaluddin, Le, Trang Diep Thanh, Le, Thao Thi Thu, Ledda, Caterina, Lee, Munjae, Lee, Seung Won, Lerango, Temesgen L, Lim, Stephen S, Liu, Chaojie, Liu, Xuefeng, Lopukhov, Platon D, Luo, Hong, Lv, Hengliang, Mahajan, Preetam Bhalchandra, Mahboobipour, Amir Ali, Majeed, Azeem, Malakan Rad, Elaheh, Malhotra, Kashish, Malik, Muhammad Sajeel Ahmed, Malinga, Lesibana Anthony, Mallhi, Tauqeer Hussain, Manilal, Aseer, Martinez-Guerra, Bernardo Alfonso, Martins-Melo, Francisco Rogerlândio, Marzo, Roy Rillera, Masoumi-Asl, Hossein, Mathur, Vasundhara, Maude, Richard James, Mehrotra, Ravi, Memish, Ziad A, Mendoza, Walter, Menezes, Ritesh G, Merza, Muayad Aghali, Mestrovic, Tomislav, Mhlanga, Laurette, Misra, Sanjeev, Misra, Arup Kumar, Mithra, Prasanna, Moazen, Babak, Mohammed, Hussen, Mokdad, Ali H, Monasta, Lorenzo, Moore, Catrin E, Mousavi, Parsa, Mulita, Francesk, Musaigwa, Fungai, Muthusamy, Raman, Nagarajan, Ahamarshan Jayaraman, Naghavi, Pirouz, Naik, Ganesh R, Naik, Gurudatta, Nair, Sanjeev, Nair, Tapas Sadasivan, Natto, Zuhair S, Nayak, Biswa Prakash, Negash, Hadush, Nguyen, Dang H, Nguyen, Van Thanh, Niazi, Robina Khan, Nnaji, Chukwudi A, Nnyanzi, Lawrence Achilles, Noman, Efaq Ali, Nomura, Shuhei, Oancea, Bogdan, Obamiro, Kehinde O, Odetokun, Ismail A, Odo, Daniel Bogale Odo, Odukoya, Oluwakemi Ololade, Oh, In-Hwan, Okereke, Chukwuma O, Okonji, Osaretin Christabel, Oren, Eyal, Ortiz-Brizuela, Edgar, Osuagwu, Uchechukwu Levi, Ouyahia, Amel, P A, Mahesh Padukudru, Parija, Pragyan Paramita, Parikh, Romil R, Park, Seoyeon, Parthasarathi, Ashwaghosha, Patil, Shankargouda, Pawar, Shrikant, Peng, Minjin, Pepito, Veincent Christian Filipino, Peprah, Prince, Perdigão, João, Perico, Norberto, Pham, Hoang Tran, Postma, Maarten J, Prabhu, Attur Ravindra Attur, Prasad, Manya, Prashant, Akila, Prates, Elton Junio Sady, Rahim, Fakher, Rahman, Mosiur, Rahman, Muhammad Aziz, Rahmati, Masoud, Rajaa, Sathish, Ramasamy, Shakthi Kumaran, Rao, Indu Ramachandra, Rao, Sowmya J, Rapaka, Deepthi, Rashid, Ahmed Mustafa, Ratan, Zubair Ahmed, Ravikumar, Nakul, Rawaf, Salman, Reddy, Murali Mohan Rama Krishna, Redwan, Elrashdy Moustafa Mohamed, Remuzzi, Giuseppe, Reyes, Luis Felipe, Rezaei, Nazila, Rezaeian, Mohsen, Rezahosseini, Omid, Rodrigues, Mónica, Roy, Priyanka, Ruela, Guilherme de Andrade, Sabour, Siamak, Saddik, Basema, Saeed, Umar, Safi, Sher Zaman, Saheb Sharif-Askari, Narjes, Saheb Sharif-Askari, Fatemeh, Sahebkar, Amirhossein, Sahiledengle, Biniyam, Sahoo, Soumya Swaroop, Salam, Nasir, Salami, Afeez Abolarinwa, Saleem, Samreen, Saleh, Mohamed A, Samadi Kafil, Hossein, Samadzadeh, Sara, Samodra, Yoseph Leonardo, Sanjeev, Rama Krishna, Saravanan, Aswini, Sawyer, Susan M, Selvaraj, Siddharthan, Senapati, Sabyasachi, Senthilkumaran, Subramanian, Shah, Pritik A, Shahid, Samiah, Shaikh, Masood Ali, Sham, Sunder, Shamshirgaran, Mohammad Ali, Shanawaz, Mohd, Sharath, Medha, Sherchan, Samendra P, Shetty, Ranjitha S, Shirzad-Aski, Hesamaddin, Shittu, Aminu, Siddig, Emmanuel Edwar, Silva, João Pedro, Singh, Surjit, Singh, Paramdeep, Singh, Harpreet, Singh, Jasvinder A, Siraj, Md Shahjahan, Siswanto, Siswanto, Solanki, Ranjan, Solomon, Yonatan, Soriano, Joan B, Sreeramareddy, Chandrashekhar T, Srivastava, Vijay Kumar, Steiropoulos, Paschalis, Swain, Chandan Kumar, Tabuchi, Takahiro, Tampa, Mircea, Tamuzi, Jacques JL Lukenze, Tat, Nathan Y, Tavakoli Oliaee, Razieh, Teklay, Gebrehiwot, Tesfaye, Edosa Geta, Tessema, Belay, Thangaraju, Pugazhenthan, Thapar, Rekha, Thum, Chern Choong Chern, Ticoalu, Jansje Henny Vera, Tleyjeh, Imad M, Tobe-Gai, Ruoyan, Toma, Temesgen Mohammed, Tram, Khai Hoan, Udoakang, Aniefiok John, Umar, Tungki Pratama, Umeokonkwo, Chukwuma David, Vahabi, Seyed Mohammad, Vaithinathan, Asokan Govindaraj, van Boven, Job F M, Varthya, Shoban Babu, Wang, Ziyue, Warsame, Muktar S A, Westerman, Ronny, Wonde, Tewodros Eshete, Yaghoubi, Sajad, Yi, Siyan, Yiğit, Vahit, Yon, Dong Keon, Yonemoto, Naohiro, Yu, Chuanhua, Zakham, Fathiah, Zangiabadian, Moein, Zeukeng, Francis, Zhang, Haijun, Zhao, Yang, Zheng, Peng, Zielińska, Magdalena, Salomon, Joshua A, Reiner Jr, Robert C, Naghavi, Mohsen, Vos, Theo, Hay, Simon I, Murray, Christopher J L, Kyu, Hmwe Hmwe · 2024 · The Lancet Infectious Diseases

Abstract

BACKGROUND: Global evaluations of the progress towards the WHO End TB Strategy 2020 interim milestones on mortality (35% reduction) and incidence (20% reduction) have not been age specific. We aimed to assess global, regional, and national-level burdens of and trends in tuberculosis and its risk factors across five separate age groups, from 1990 to 2021, and to report on age-specific progress between 2015 and 2020. METHODS: We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 (GBD 2021) analytical framework to compute age-specific tuberculosis mortality and incidence estimates for 204 countries and territories (1990-2021 inclusive). We quantified tuberculosis mortality among individuals without HIV co-infection using 22 603 site-years of vital registration data, 1718 site-years of verbal autopsy data, 825 site-years of sample-based vital registration data, 680 site-years of mortality surveillance data, and 9 site-years of minimally invasive tissue sample (MITS) diagnoses data as inputs into the Cause of Death Ensemble modelling platform. Age-specific HIV and tuberculosis deaths were established with a population attributable fraction approach. We analysed all available population-based data sources, including prevalence surveys, annual case notifications, tuberculin surveys, and tuberculosis mortality, in DisMod-MR 2.1 to produce internally consistent age-specific estimates of tuberculosis incidence, prevalence, and mortality. We also estimated age-specific tuberculosis mortality without HIV co-infection that is attributable to the independent and combined effects of three risk factors (smoking, alcohol use, and diabetes). As a secondary analysis, we examined the potential impact of the COVID-19 pandemic on tuberculosis mortality without HIV co-infection by comparing expected tuberculosis deaths, modelled with trends in tuberculosis deaths from 2015 to 2019 in vital registration data, with observed tuberculosis deaths in 2020 and 2021 for countries with available cause-specific mortality data. FINDINGS: We estimated 9·40 million (95% uncertainty interval [UI] 8·36 to 10·5) tuberculosis incident cases and 1·35 million (1·23 to 1·52) deaths due to tuberculosis in 2021. At the global level, the all-age tuberculosis incidence rate declined by 6·26% (5·27 to 7·25) between 2015 and 2020 (the WHO End TB strategy evaluation period). 15 of 204 countries achieved a 20% decrease in all-age tuberculosis incidence between 2015 and 2020, eight of which were in western sub-Saharan Africa. When stratified by age, global tuberculosis incidence rates decreased by 16·5% (14·8 to 18·4) in children younger than 5 years, 16·2% (14·2 to 17·9) in those aged 5-14 years, 6·29% (5·05 to 7·70) in those aged 15-49 years, 5·72% (4·02 to 7·39) in those aged 50-69 years, and 8·48% (6·74 to 10·4) in those aged 70 years and older, from 2015 to 2020. Global tuberculosis deaths decreased by 11·9% (5·77 to 17·0) from 2015 to 2020. 17 countries attained a 35% reduction in deaths due to tuberculosis between 2015 and 2020, most of which were in eastern Europe (six countries) and central Europe (four countries). There was variable progress by age: a 35·3% (26·7 to 41·7) decrease in tuberculosis deaths in children younger than 5 years, a 29·5% (25·5 to 34·1) decrease in those aged 5-14 years, a 15·2% (10·0 to 20·2) decrease in those aged 15-49 years, a 7·97% (0·472 to 14·1) decrease in those aged 50-69 years, and a 3·29% (-5·56 to 9·07) decrease in those aged 70 years and older. Removing the combined effects of the three attributable risk factors would have reduced the number of all-age tuberculosis deaths from 1·39 million (1·28 to 1·54) to 1·00 million (0·703 to 1·23) in 2020, representing a 36·5% (21·5 to 54·8) reduction in tuberculosis deaths compared to those observed in 2015. 41 countries were included in our analysis of the impact of the COVID-19 pandemic on tuberculosis deaths without HIV co-infection in 2020, and 20 countries were included in the analysis for 2021. In 2020, 50 900 (95% CI 49 700 to 52 400) deaths were expected across all ages, compared to an observed 45 500 deaths, corresponding to 5340 (4070 to 6920) fewer deaths; in 2021, 39 600 (38 300 to 41 100) deaths were expected across all ages compared to an observed 39 000 deaths, corresponding to 657 (-713 to 2180) fewer deaths. INTERPRETATION: Despite accelerated progress in reducing the global burden of tuberculosis in the past decade, the world did not attain the first interim milestones of the WHO End TB Strategy in 2020. The pace of decline has been unequal with respect to age, with older adults (ie, those aged >50 years) having the slowest progress. As countries refine their national tuberculosis programmes and recalibrate for achieving the 2035 targets, they could consider learning from the strategies of countries that achieved the 2020 milestones, as well as consider targeted interventions to improve outcomes in older age groups. FUNDING: Bill & M

Overview

CoChat Summary

TL;DR

In GBD 2021, global tuberculosis incidence fell by 6·26% and tuberculosis deaths by 11·9% between 2015 and 2020, missing the WHO End TB Strategy 2020 milestones of 20% incidence reduction and 35% mortality reduction. Progress was unequal by age, with older adults improving slowest, while removing smoking, alcohol use, and diabetes would have reduced 2020 tuberculosis deaths by 36·5% versus 2015.

Key findings

  • In 2021, there were an estimated 9·40 million (95% UI 8·36–10·5) tuberculosis incident cases and 1·35 million (1·23–1·52) tuberculosis deaths; HIV–tuberculosis co-infection accounted for 1·00 million (0·90–1·13) incident cases and 205 000 (158 000–248 000) deaths.
  • From 2015 to 2020, the global all-age tuberculosis incidence rate declined by 6·26% (5·27–7·25) and global tuberculosis deaths declined by 11·9% (5·77–17·0); 15 of 204 countries achieved a 20% decrease in all-age incidence, and the abstract reports 17 countries attained a 35% reduction in deaths (the results text reports 19 countries/territories achieving this milestone).
  • Age-specific incidence declines from 2015 to 2020 were largest in children younger than 5 years (16·5% [14·8–18·4]) and those aged 5–14 years (16·2% [14·2–17·9]), versus 6·29% (5·05–7·70) in ages 15–49, 5·72% (4·02–7·39) in ages 50–69, and 8·48% (6·74–10·4) in ages ≥70; death declines were 35·3% (26·7–41·7), 29·5% (25·5–34·1), 15·2% (10·0–20·2), 7·97% (0·472–14·1), and 3·29% (–5·56 to 9·07), respectively.
  • Removing the combined effects of smoking, alcohol use, and diabetes would have reduced all-age tuberculosis deaths from 1·39 million (1·28–1·54) to 1·00 million (0·703–1·23) in 2020, a 36·5% (21·5–54·8) reduction versus observed 2015 deaths; corresponding reductions were 31·0% (15·9–48·8) in ages 15–49, 40·5% (22·3–62·6) in ages 50–69, and 41·0% (25·4–62·0) in ages ≥70. In the COVID-19 secondary analysis, 41 countries had 50 900 expected versus 45 500 observed tuberculosis deaths without HIV co-infection in 2020 (5 340 [4 070–6 920] fewer), and 20 countries had 39 600 expected versus 39 000 observed in 2021 (657 [–713 to 2 180] fewer).

Methods

  • GBD 2021 analytical framework was used to compute age-specific tuberculosis mortality and incidence estimates for 204 countries and territories from 1990 to 2021. Tuberculosis mortality without HIV co-infection was modelled with CODEm using 22 603 site-years of vital registration data, 1 718 site-years of verbal autopsy data, 825 site-years of sample-based vital registration data, 680 site-years of mortality surveillance data, and 9 site-years of minimally invasive tissue sample diagnoses; HIV–tuberculosis deaths were estimated with a population attributable fraction approach.
  • Tuberculosis morbidity was modelled in DisMod-MR 2.1 using prevalence surveys, annual case notifications, tuberculin surveys, and tuberculosis mortality data to produce internally consistent age-specific incidence, prevalence, and mortality estimates; incidence for countries with low-quality cause-of-death data was predicted via a mortality-to-incidence ratio approach, and incidence was disaggregated by HIV status.
  • Risk-factor analysis computed age-sex-specific population attributable fractions for smoking, alcohol consumption, and diabetes among adults without HIV co-infection, then derived risk-deleted mortality rates. The COVID-19 secondary analysis used quasi-Poisson regression on 2015–2019 vital registration data to predict expected tuberculosis deaths in 2020–21 for countries with available cause-specific mortality data, stratified by ages <65 years, ≥65 years, and all ages.

Limitations

  • The paper states that the primary limitation is data availability, with gaps across countries, age groups, and years; in the absence of data, estimates depended on covariates, spatial relationships, and out-of-sample predictive validity, and data scarcity is reflected in larger uncertainty intervals, with particular triangulation challenges in sub-Saharan Africa.
  • The paper states it could not quantify tuberculosis mortality attributable to all important risk factors, excluding indoor air pollution and malnutrition, nor burden attributable to social determinants such as poverty and educational attainment; PAF estimates assume causality without confounding, that exposure removal does not affect unrelated risk factors, and that feasible interventions exist, and Levin’s formula may be biased although bias is often small with adjusted relative risks.
  • The paper states that the COVID-19 impact could not be fully quantified due to insufficient empirical evidence and was restricted to 41 countries with available data, limiting generalisability; the text also makes evident that GBD 2021 and WHO 2022 estimates diverged for 2020–21 because of different modelling assumptions, and the authors discuss possible misclassification of COVID-19 deaths as tuberculosis deaths as an unresolved issue.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(24)00007-0

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Global age-specific all-form tuberculosis incidence rates (A) and deaths (B), 1990–2021 The dashed grey lines indicate WHO End TB Strategy 2020 milestones (20% reduction in incidence rates and 35% reduction in deaths compared with 2015). The shaded areas represent 95% uncertainty intervals.
Figure 1 Global age-specific all-form tuberculosis incidence rates (A) and deaths (B), 1990–2021 The dashed grey lines indicate WHO End TB Strategy 2020 milestones (20% reduction in incidence rates and 35% reduction in deaths compared with 2015). The shaded areas represent 95% uncertainty intervals.CC BY · PubMed Central
Figure 2 Percentage change from 2015 to 2020 in all-age, all-form tuberculosis incidence rates per 100 000 population (A) and deaths (B)
Figure 2 Percentage change from 2015 to 2020 in all-age, all-form tuberculosis incidence rates per 100 000 population (A) and deaths (B)CC BY · PubMed Central
Figure 3 Observed versus predicted tuberculosis deaths for all countries with available cause-specific vital registration data combined from 2015 to 2020 (A) and 2021 (B) Observed tuberculosis deaths represent tuberculosis deaths without HIV co-infection from vital registration data. 41 countries had data up to 2020 and 20 countries had data up to 2021. Green circles represent observed tuberculosis deaths aggregated across included countries. Solid lines are aggregated predicted values from country-specific and age-specific quasi-Poisson regressions, with vital registration data from 2015 to 2019 used as inputs; the shaded areas represent the corresponding 95% CIs. Complete country-specific results are included in appendix 2 (pp 300–04).
Figure 3 Observed versus predicted tuberculosis deaths for all countries with available cause-specific vital registration data combined from 2015 to 2020 (A) and 2021 (B) Observed tuberculosis deaths represent tuberculosis deaths without HIV co-infection from vital registration data. 41 countries had data up to 2020 and 20 countries had data up to 2021. Green circles represent observed tuberculosis deaths aggregated across included countries. Solid lines are aggregated predicted values from country-specific and age-specific quasi-Poisson regressions, with vital registration data from 2015 to 2019 used as inputs; the shaded areas represent the corresponding 95% CIs. Complete country-specific results are included in appendix 2 (pp 300–04).CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 0 Not valid · 36 Not checked · 127 Own results and interpretations

96 more claims

Create a free account to see all 176 claims and to verify the 50 references still open.

See all claims — free account
  • It may state two separate claims as one. 51
  • Probably not a substantial claim. 38

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 106 references

Research works printed but not linked: 2

  1. Byng-Maddick, 2016, Does tuberculosis threaten our ageing populations?, BMC Infect Dis, 16, 119, 10.1186/s12879-016-1451-0 · DOI · Paper page
  2. Casco, 2023, Long-term outcomes of the global TB and COVID-19 coinfection cohort, Eur Respir J, 62

Cited by

See all 205

Metadata

Authors
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., Nicholson, S. I., Stafford, L. K., Carter, A., Ross, J. M., Abbastabar, H., Abdoun, M., Abdulah, D. M., Aboagye, R. G., Abolhassani, H., Abrha, W. A., Abubaker Ali, H., Abu-Gharbieh, E., Aburuz, S., Addo, I. Y., Adepoju, A. V., Adhikari, K., Adnani, Q. E. S., Adra, S., Afework, A., Aghamiri, S., Agyemang-Duah, W., Ahinkorah, B. O., Ahmad, D., Ahmad, S., Ahmadzade, A. M., Ahmed, H., Ahmed, M., Ahmed, A., Akinosoglou, K., AL-Ahdal, T. M. A., Alam, N., Albashtawy, M., AlBataineh, M. T., Al-Gheethi, A. A. S., Ali, A., Ali, E. A., Ali, L., Ali, Z., Ali, S. S. S., Allel, K., Altaf, A., Al-Tawfiq, J. A., Alvis-Guzman, N., Alvis-Zakzuk, N. J., Amani, R., Amusa, G. A., Amzat, J., Andrews, J. R., Anil, A., Anwer, R., Aravkin, A. Y., Areda, D., Artamonov, A. A., Aruleba, R. T., Asemahagn, M. A., Atre, S. R., Aujayeb, A., Azadi, D., Azadnajafabad, S., Azzam, A. Y., Badar, M., Badiye, A. D., Bagherieh, S., Bahadorikhalili, S., Baig, A. A., Banach, M., Banik, B., Bardhan, M., Barqawi, H. J., Basharat, Z., Baskaran, P., Basu, S., Beiranvand, M., Belete, M. A., Belew, M. A., Belgaumi, U. I., Beloukas, A., Bettencourt, P. J. G., Bhagavathula, A. S., Bhardwaj, N., Bhardwaj, P., Bhargava, A., Bhat, V., Bhatti, J. S., Bhatti, G. K., Bikbov, B., Bitra, V. R., Bjegovic-Mikanovic, V., Buonsenso, D., Burkart, K., Bustanji, Y., Butt, Z. A., Camargos, P., Cao, Y., Carr, S., Carvalho, F., Cegolon, L., Cenderadewi, M., Cevik, M., Chahine, Y., Chattu, V. K., Ching, P. R., Chopra, H., Chung, E., Claassens, M. M., Coberly, K., Cruz-Martins, N., Dabo, B., Dadana, S., Dadras, O., Darban, I., Darega Gela, J., Darwesh, A. M., Dashti, M., Demessa, B. H., Demisse, B., Demissie, S., Derese, A. M. A., Deribe, K., Desai, H. D., Devanbu, V. G. C., Dhali, A., Dhama, K., Dhingra, S., Do, T. H. P., Dongarwar, D., Dsouza, H. L., Dube, J., Dziedzic, A. M., Ed-Dra, A., Efendi, F., Effendi, D. E., Eftekharimehrabad, A., Ekadinata, N., Ekundayo, T. C., Elhadi, M., Elilo, L. T., Emeto, T. I., Engelbert Bain, L., Fagbamigbe, A. F., Fahim, A., Feizkhah, A., Fetensa, G., Fischer, F., Gaipov, A., Gandhi, A. P., Gautam, R. K., Gebregergis, M. W., Gebrehiwot, M., Gebrekidan, K. G., Ghaffari, K., Ghassemi, F., Ghazy, R. M., Goodridge, A., Goyal, A., Guan, S.-Y., Gudeta, M. D., Guled, R. A., Gultom, N. B., Gupta, V. B., Gupta, V. K., Gupta, S., Hagins, H., Hailu, S. G., Hailu, W. B., Hamidi, S., Hanif, A., Harapan, H., Hasan, R. S., Hassan, S., Haubold, J., Hezam, K., Hong, S. H., Horita, N., Hossain, M. B., Hosseinzadeh, M., Hostiuc, M., Hostiuc, S., Huynh, H.-H., Ibitoye, S. E., Ikuta, K. S., Ilic, I. M., Ilic, M. D., Islam, M. R., Ismail, N. E., Ismail, F., Jafarzadeh, A., Jakovljevic, M., Jalili, M., Janodia, M. D., Jomehzadeh, N., Jonas, J. B., Joseph, N., Joshua, C. E., Kabir, Z., Kamble, B. D., Kanchan, T., Kandel, H., Kanmodi, K. K., Kantar, R. S., Karaye, I. M., Karimi Behnagh, A., Kassa, G. G., Kaur, R. J., Kaur, N., Khajuria, H., Khamesipour, F., Khan, Y. H., Khan, M. N., Khan Suheb, M. Z., Khatab, K., Khatami, F., Kim, M. S., Kosen, S., Koul, P. A., Koulmane Laxminarayana, S. L., Krishan, K., Kucuk Bicer, B., Kuddus, M. A., Kulimbet, M., Kumar, N., Lal, D. K., Landires, I., Latief, K., Le, T. D. T., Le, T. T. T., Ledda, C., Lee, M., Lee, S. W., Lerango, T. L., Lim, S. S., Liu, C., Liu, X., Lopukhov, P. D., Luo, H., Lv, H., Mahajan, P. B., Mahboobipour, A. A., Majeed, A., Malakan Rad, E., Malhotra, K., Malik, M. S. A., Malinga, L. A., Mallhi, T. H., Manilal, A., Martinez-Guerra, B. A., Martins-Melo, F. R., Marzo, R. R., Masoumi-Asl, H., Mathur, V., Maude, R. J., Mehrotra, R., Memish, Z. A., Mendoza, W., Menezes, R. G., Merza, M. A., Mestrovic, T., Mhlanga, L., Misra, S., Misra, A. K., Mithra, P., Moazen, B., Mohammed, H., Mokdad, A. H., Monasta, L., Moore, C. E., Mousavi, P., Mulita, F., Musaigwa, F., Muthusamy, R., Nagarajan, A. J., Naghavi, P., Naik, G. R., Naik, G., Nair, S., Nair, T. S., Natto, Z. S., Nayak, B. P., Negash, H., Nguyen, D. H., Nguyen, V. T., Niazi, R. K., Nnaji, C. A., Nnyanzi, L. A., Noman, E. A., Nomura, S., Oancea, B., Obamiro, K. O., Odetokun, I. A., Odo, D. B. O., Odukoya, O. O., Oh, I.-H., Okereke, C. O., Okonji, O. C., Oren, E., Ortiz-Brizuela, E., Osuagwu, U. L., Ouyahia, A., P A, M. P., Parija, P. P., Parikh, R. R., Park, S., Parthasarathi, A., Patil, S., Pawar, S., Peng, M., Pepito, V. C. F., Peprah, P., Perdigão, J., Perico, N., Pham, H. T., Postma, M. J., Prabhu, A. R. A., Prasad, M., Prashant, A., Prates, E. J. S., Rahim, F., Rahman, M., Rahman, M. A., Rahmati, M., Rajaa, S., Ramasamy, S. K., Rao, I. R., Rao, S. J., Rapaka, D., Rashid, A. M., Ratan, Z. A., Ravikumar, N., Rawaf, S., Reddy, M. M. R. K., Redwan, E. M. M., Remuzzi, G., Reyes, L. F., Rezaei, N., Rezaeian, M., Rezahosseini, O., Rodrigues, M., Roy, P., Ruela, G. D. A., Sabour, S., Saddik, B., Saeed, U., Safi, S. Z., Saheb Sharif-Askari, N., Saheb Sharif-Askari, F., Sahebkar, A., Sahiledengle, B., Sahoo, S. S., Salam, N., Salami, A. A., Saleem, S., Saleh, M. A., Samadi Kafil, H., Samadzadeh, S., Samodra, Y. L., Sanjeev, R. K., Saravanan, A., Sawyer, S. M., Selvaraj, S., Senapati, S., Senthilkumaran, S., Shah, P. A., Shahid, S., Shaikh, M. A., Sham, S., Shamshirgaran, M. A., Shanawaz, M., Sharath, M., Sherchan, S. P., Shetty, R. S., Shirzad-Aski, H., Shittu, A., Siddig, E. E., Silva, J. P., Singh, S., Singh, P., Singh, H., Singh, J. A., Siraj, M. S., Siswanto, S., Solanki, R., Solomon, Y., Soriano, J. B., Sreeramareddy, C. T., Srivastava, V. K., Steiropoulos, P., Swain, C. K., Tabuchi, T., Tampa, M., Tamuzi, J. J. L., Tat, N. Y., Tavakoli Oliaee, R., Teklay, G., Tesfaye, E. G., Tessema, B., Thangaraju, P., Thapar, R., Thum, C. C. C., Ticoalu, J. H. V., Tleyjeh, I. M., Tobe-Gai, R., Toma, T. M., Tram, K. H., Udoakang, A. J., Umar, T. P., Umeokonkwo, C. D., Vahabi, S. M., Vaithinathan, A. G., van Boven, J. F. M., Varthya, S. B., Wang, Z., Warsame, M. S. A., Westerman, R., Wonde, T. E., Yaghoubi, S., Yi, S., Yiğit, V., Yon, D. K., Yonemoto, N., Yu, C., Zakham, F., Zangiabadian, M., Zeukeng, F., Zhang, H., Zhao, Y., Zheng, P., Zielińska, M., Salomon, J. A., Reiner Jr, R. C., Naghavi, M., Vos, T., Hay, S. I., Murray, C. J. L., & Kyu, H. H.
Affiliations
University of Washington (US)
ORCID
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2024-07
Volume
24
Issue
7
Pages
698-725
ISSN
1473-3099 (ISSN-L)
OpenAlex
W4392970825
Cited by
146
References
106
Citations by year
2026: 54 · 2025: 70 · 2024: 21
FWCI
50.21
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Infectious Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Charles Sturt University Research Output (CRO) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by)
  • Teesside University Research Portal (Teesside University) (acceptedVersion, cc-by)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • Pure (Coventry University) (acceptedVersion, cc-by)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) (acceptedVersion)
  • ResearchOnline - JCU (James Cook University) (submittedVersion)
  • Lirias (KU Leuven) (submittedVersion, cc-by)
  • AJOU Open Repository (Ajou University) (submittedVersion)
  • Kocaeli Üniversitesi - AVESİS (submittedVersion)
  • eCommons - AKU (Aga Khan University) (submittedVersion)
  • National University of Singapore (submittedVersion)
  • Touro Scholar (Touro College) (submittedVersion)
  • FedUni ResearchOnline (Federation University Australia) (submittedVersion, cc-by)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by-nc-nd)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Intellectum (Universidad de La Sabana) (submittedVersion, cc-by-nc-nd)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • ANU Open Research (Australian National University) (submittedVersion, cc-by)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
Funders
Bill & Melinda Gates Foundation
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
tuberculosis, End TB Strategy, age-specific mortality, tuberculosis incidence, HIV coinfection, smoking, alcohol consumption, diabetes mellitus, risk factors, COVID-19 pandemic impact, tuberculosis control, tuberculosis prevalence, tuberculosis incidence trends, population attributable fraction
MeSH terms
Global Burden of Disease, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Risk Factors, Tuberculosis, Global Health, World Health Organization, HIV Infections, Incidence, Young Adult, Coinfection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. https://app.cochat.ai/papers/10.1016/s1473-3099(24)00007-0
The paper
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., Nicholson, S. I., Stafford, L. K., Carter, A., Ross, J. M., Abbastabar, H., Abdoun, M., Abdulah, D. M., Aboagye, R. G., Abolhassani, H., . . . Kyu, H. H. (2024). Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(24)00007-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.